Purpose: Apoptosis plays a crucial role in normal development and mediates
tumor response to chemotherapy. This study investigated the pattern of apop
totic gene expression in brain tumor tissue specimens and cell lines.
Materials and Methods: BCL2, BCLXL, BCLXS, and BAX transcripts were amplifi
ed using reverse transcriptase polymerase chain reaction in 7 high-grade gl
iomas (HGGs), 7 ependymomas, and 6 cell lines (2 glioblastomas, 3 medullobl
astomas, and 1 supratentorial-primitive neuroectodermal tumor [PNET]). Immu
nohistochemical staining for BCL2, BCLX, BAX, and p53 was performed in 7 pe
diatric low-grade gliomas (LGGs) and 7 pediatric HGGs.
Results: Six of seven gliomas, all ependymomas, and all glioblastoma and me
dulloblastoma cell lines expressed BCLXL and BAX. BCL2 expression was only
detected in the supratentorial PNET Line PFSK. BCLXS was absent in all tumo
rs. By immunohistochemistry, no glial tumors stained positively for BCL2. S
imilar BAX and BCLX protein expression was observed in LGG and HGG. Three o
f five glioblastomas showed significant p53 expression.
Conclusions: Coexpression of proapoptotic and antiapoptotic genes in human
brain tumors supports the hypothesis that the relative expression of compet
ing genes determines apoptotic threshold.